We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance for Developing Hepatotoxic Assay

By Biotechdaily staff writers
Posted on 05 Oct 2006
Bionas GmbH (Rostock, Germany) and Primacyt (Schwerin, Germany), are cooperating on the development of a cell-based assay using primary human hepatocytes for predicting hepatotoxic effects in response to test compounds. More...


Primary human hepatocytes, provided by Primacyt, are cultivated directly on collagen-coated Bionas metabolic chips SC1000 with Primacyt's chemically defined media. The chips are then placed into the Bionas 2500 analyzing system to evaluate the effects of test compounds. After a recovery period, the hepatocytes can be re-used for further experiments in the Bionas 2500 analyzing system.

Predicting liver toxicity is a major concern, and non-immortalized primary human hepatocytes can be used as biosensors for the analysis of drugs, food additives, and chemicals. A cell-based assay based on the Bionas 2500 analyzing system and primary hepatocytes may aid compound selection in the drug discovery process and may reduce both the number of animal studies and preclinical development time.

Bionas specializes in analyzing systems and services for in-vitro profiling of the metabolic activity of cells to understand cellular function. The Bionas 2500 analyzing system measures extracellular acidification, oxygen consumption, and cell adhesion in a label-free and non-invasive manner, and can be applied to various cell types including primary cells. The readout is carried out continuously and can be watched online. Main applications include drug profiling, lead optimization, pharmaco kinetics, and early toxicology programs.

Primacyt cell culture technology offers a validated, serum-free, long-term human hepatocyte culture system. Hepac2 serves as a biosensor for the toxicologic analysis of drugs, food additives, and chemicals and their impact on hepatocellular metabolism and functions.



Related Links:
Bionas
Primacyt

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Platelet Function Analyzer
PL-12
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.